Latest Non-steroidal anti-inflammatory drugs Stories
The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk.
Conclusions of a new study do not help to ease any confusion over whether use of painkillers reduces the risk of developing the dangerous skin cancer melanoma.
HONG KONG, March 24 /PRNewswire-FirstCall/ - AlphaRx Inc. (OTC BB:ALRX.OB) has received a Notice of Allowance from the United States Patent and Trademark Office for its lead pain product candidate code named ARX8203, a potentially safer drug intended for pain treatment.
After many years of gradual increase followed by a three-year levelling off period, sales of addictive anxiolytic and hypnotic drugs decreased by just under two per cent in 2010.
The reduced risk of colorectal cancer associated with taking aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may be confined to individuals already at risk because of elevations in a particular inflammatory factor in the blood.
Researchers found that ibuprofen may offer protection against developing Parkinson's disease.
The over-the-counter drug, ibuprofen, may offer protection against developing Parkinsonâ€™s disease.
Men who use non-steroidal anti-inflammatory drugs (NSAIDs) three times a day for more than three months are 38 percent more likely to have erectile dysfunction (ED) as men who do not regularly take these drugs.
According to a new report from the American Academy of Pediatrics (AAP), researchers say parents should not immediately rush for medicines when their child displays signs of fever, as fever alone is not a cause for intervention.
New research shows that medications which have raised safety concerns over heart attack and stroke risks may not have gotten approval from the Food and Drug Administration (FDA) if the cardiovascular effects of fluid retention had been better understood.
More Images (1 images) »